Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, December 12, 2018
[ Wed, Dec 12th 2018
] - WOPRAI
[ Wed, Dec 12th 2018
] - WOPRAI
[ Wed, Dec 12th 2018
] - WOPRAI
[ Wed, Dec 12th 2018
] - WOPRAI
[ Wed, Dec 12th 2018
] - WOPRAI
[ Wed, Dec 12th 2018
] - WOPRAI
[ Wed, Dec 12th 2018
] - WOPRAI
[ Wed, Dec 12th 2018
] - WOPRAI
[ Wed, Dec 12th 2018
] - WOPRAI
[ Wed, Dec 12th 2018
] - WOPRAI
Tue, December 11, 2018
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI
Derek Archila Downgraded (VNDA) to Hold and Held Target at $29 on, Dec 11th, 2018
Derek Archila of Oppenheimer, Downgraded "Vanda Pharmaceuticals Inc." (VNDA) to Hold and Held Target at $29 on, Dec 11th, 2018.
Derek has made no other calls on VNDA in the last 4 months.
There are 3 other peers that have a rating on VNDA. Out of the 3 peers that are also analyzing VNDA, 0 agree with Derek's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Derek
- Joel Beatty of "Citigroup" Maintained at Strong Buy with Increased Target to $47 on, Friday, December 7th, 2018
- Charles Duncan of "Cantor Fitzgerald" Upgraded from Hold to Buy and Held Target at $43 on, Tuesday, December 4th, 2018
- Chris Howerton of "Jefferies" Initiated at Strong Buy and Held Target at $26 on, Thursday, November 8th, 2018
